Regeneron Pharmaceuticals Dashboard
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals is a biotechnology company focused on discovering and developing innovative medicines. Its portfolio includes treatments for eye disease, cancer, cardiovascular conditions, and inflammatory disorders. The company leverages proprietary technologies to accelerate drug discovery and development. Regeneron maintains strong research-driven growth and high-margin products. Long-term performance is supported by a deep clinical pipeline.
Sector: Healthcare
Founded: 1988
Headquarters: Tarrytown, United States
Website: regeneron.com